Diagnostic Reagents and Tests

Displaying 1 - 5 of 5 products

HCC Biomarkers - Patient Information

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is the third leading cause of cancer-related death in the world. Major risk factors for liver cancer include...

More Details

HCC Biomarkers - Information for Health Care Providers

The HCC Biomarker tests AFP-L3 and DCP are in vitro diagnostic blood tests for the risk assessment of developing Hepatocellular Carcinoma (HCC). Both tests are used in conjunction with...

More Details

µTASWako™ AFP-L3 Test

µTASWako™ AFP-L3 Test is an in vitro diagnostic blood test for the risk assessment of developing Hepatocellular Carcinoma (HCC).

AFP-L3 is an isoform of the glycoprotein alpha-...

More Details

µTASWako™ DCP Test

µTASWako™ DCP Test is an in vitro diagnostic blood test for the risk assessment of developing Hepatocellular Carcinoma (HCC).

DCP (des-gamma-carboxy prothrombin) is an immature...

More Details

µTASWako™ i30

µTASWako™ i30 (Micro Total Analysis System) is the worldwide unique system for the automated measurement of the biomarkers AFP-L3 and DCP.

Both, AFP-L3 (lectin-reactive alpha-...

More Details